Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Assess lot-to-lot consistency of 3 lots (double blind design) of GlaxoSmithKline Biologicals' 10-valent pneumococcal vaccine and evaluate non-inferiority to Prevenarâ„¢ (single blind design) when administered as 3-dose primary immunization course before 6 months of age
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
105553
NCT00307554
Infections, Streptococcal
Phase 3
 
Follow on studies 107046, 112640, 111345,111346, and 111347 were conducted. An annotated case report form is not available for this study. A blank case report form will be provided.
October 2014

Powered by ideaPoint, Inc.